Prestige Consumer Healthcare

$38.34
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.24 (+0.63%) As of 3:19 PM UTC today

Why Robinhood?

You can buy or sell PBH and other stocks, options, and ETFs commission-free!

About PBH

Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare, and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY. The listed name for PBH is Prestige Consumer Healthcare Inc.

CEO

Ronald M. Lombardi

Employees

520

Headquarters

Tarrytown, New York

Founded

1996

Market Cap

1.89B

Price-Earnings Ratio

11.83

Dividend Yield

—

Average Volume

385.83K

High Today

$38.51

Low Today

$37.92

Open Price

$38.08

Volume

23.29K

52 Week High

$46.12

52 Week Low

$27.40

Collections

Technology

Health

Healthcare

Advertising and Marketing

Analyst Ratings

43%

of 7 ratings

Buy

43%

Hold

57%

Sell

PBH Earnings

$0.00

$0.29

$0.57

$0.86

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Available Feb 4, Pre-Market